NCT03073551

Brief Summary

Gestational diabetes mellitus (GDM) affects up to 3-5% of all pregnancies. When diagnosed with GDM, women undergo nutritional counseling, blood sugars monitoring and are encouraged to exercise regularly. Women who do not meet therapeutic targets may need to add insulin injections. Activity promoting video games are an attractive possibility for improvement of exercise compliance. The objective of this study is to determine whether providing women recently diagnosed with GDM with a Nintendo Wii™ activity promoting gaming platform will increase activity levels, improve glycemic control of sugar levels and decrease the need for supplementary insulin treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2010

Completed
6.5 years until next milestone

First Submitted

Initial submission to the registry

February 3, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 8, 2017

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

April 29, 2020

Status Verified

April 1, 2020

Enrollment Period

12 years

First QC Date

February 3, 2017

Last Update Submit

April 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glucose levels

    Mean fasting and post-prandial glucose levels

    Measured from study intake date until 36 weeks gestation

Secondary Outcomes (3)

  • Insulin therapy

    Measured from study intake date until 36 weeks gestation

  • Activity level

    Measured from study intake date until 36 weeks gestation

  • Maternal weight gain

    Weight gained during pregnancy, measured from start of pregnancy (1 week gestation) to end of pregnancy (up to 40 weeks gestation).

Study Arms (2)

Control Group

NO INTERVENTION

Participants in this group will receive diabetic care and education as per the standard of care. They will also be given a pedometer and will be instructed to record their number of steps at the end of each day

Wii Group

ACTIVE COMPARATOR

Participants in this group will receive diabetic care and education as per the standard of care. They will also be given a Wii console and game to take home. Participants will be instructed on how to set up and use the Wii. These participants will also be given a pedometer and will be instructed to record their number of steps at the end of each day.

Other: Wii Group

Interventions

Participants in the Wii group will be given a Wii console and video game to take home. The console includes a Wii balance board and remote controller. The Wii Fit game allows participants to choose different types of exercise such as yoga, aerobics, balance training, and more. Participant movements are shown on screen as they move with the balance board and remote control.

Wii Group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipants must be pregnant women
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women diagnosed with gestational diabetes and a singleton pregnancy at 24-36 weeks of gestation.

You may not qualify if:

  • Multiple gestation
  • Pre-gestational diabetes
  • Unable to provide informed consent
  • Any contraindication to performing physical activity in pregnancy (e.g. increased risk of preterm delivery)
  • Has and regularly uses a Nintendo Wii console
  • Presence of co-morbidities including: Hypertension (systolic pressure \> 160 mmHg and/or diastolic pressure \> 100 mmHg), alcohol abuse (i.e. 2 glasses alcohol or more per day); drug abuse, use of the medication that affects insulin secretion or insulin sensitivity (antiviral, corticosteroids, antihypertensive drugs, all concomitant medication will be discussed); serious pulmonary (COPD, exercise induced asthma), cardiac, hepatic or renal (serum creatinine \> 150 μmol/l) impairment; malignant disease; serious mental or physical impairment (limiting the ability to understand or implement the study protocol).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Howard Berger, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The control group will receive diabetes treatment and education as per standard of care. The intervention group will receive diabetes treatment and education as per standard of care, and will also be given a Wii game console to bring home.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2017

First Posted

March 8, 2017

Study Start

July 27, 2010

Primary Completion

August 1, 2022

Study Completion

August 1, 2022

Last Updated

April 29, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share